Missouri’s Adult-Use Cannabis Sales Exceeded $1.4 Billion in Its First Year

Table of Contents
In the sovereign State of Missouri, the advent of legalized cannabis transactions for recreational purposes in its inaugural year has yielded a remarkable financial milestone, with sales surging beyond the formidable benchmark of $1.4 billion. This substantial sum, meticulously tallied and disseminated by the esteemed Department of Health and Senior Services of the state, encompasses an impressive $1.13 billion attributed to purchases for adult recreational indulgence. Additionally, the burgeoning market for medical cannabis contributed a commendable $280 million to the overarching sales volume, underscoring the multifaceted dynamics of the evolving cannabis industry within the jurisdiction.
The commencement of authorized cannabis sales to individuals aged 21 and above, a watershed moment in the state’s regulatory landscape, was ceremoniously marked in February of the antecedent year. The zenith of retail activity, a testament to the burgeoning consumer demand, was notably observed in December, wherein aficionados and enthusiasts alike partook in transactions amounting to a noteworthy $106.5 million within the bounds of the meticulously crafted regulatory framework.
Conversely, the subsequent month of January in the current annum witnessed a marginal decline in recreational cannabis sales, with transactions totaling $94.8 million. This nuanced shift, while indicative of a fluctuation, represents a discernible deviation from the established trend, marking the first decrement observed since the preceding month of May.
In tandem, the realm of medical cannabis in Missouri has borne witness to a discernible downtrend after the advent of the recreational market. The month of January bore witness to medical cannabis transactions amounting to $15 million, reflecting a notable decline from the corresponding figure of $37 million recorded in January of the antecedent year.
Furthermore, the precipitous decline in the rate of patient enrollment within the state’s medical cannabis program has elicited keen observation, with participation levels plummeting to near-historic lows. This observed trend is mirrored by a concomitant reduction in the monthly issuance of business licenses by competent regulatory bodies. Indeed, it is a salient phenomenon observed across various jurisdictions that the inauguration of retail outlets, characterized by their accessibility and absence of requisite medical consultations or enrollment in state-administered registries, invariably precipitates a discernible decline in both enrollment and transactional activity within the medical cannabis sphere.
Missouri Cannabis Sales by Month

In an extensive retrospective analysis spanning back to the inception of medical cannabis transactions within the state in October 2020, licensed retail establishments in Missouri have unveiled a comprehensive aggregate exceeding $2 billion in lawful cannabis product sales. As of the preceding month, this cumulative sum had surged to an impressive $2.05 billion, marking a significant milestone meticulously documented by the esteemed Greenway Magazine, an authoritative publication in the realm of cannabis affairs.
Andrew Mullins, the distinguished Executive Director of MoCannTrade, a prominent trade association wielding considerable influence within the industry, expounded upon these monumental figures in a press release disseminated by the aforementioned magazine. Mullins articulated, with eloquence and conviction, that “The inaugural year of lawful, taxed, and meticulously scrutinized adult-use cannabis transactions in Missouri has not only served as a catalyst for the creation of thousands of employment opportunities but has also invigorated local economies, facilitated the expunction of over 100,000 prior criminal records, and has generated substantial financial contributions towards the welfare of our esteemed veterans.”
Furthermore, Mullins elucidated, “With the electorate of Missouri having unequivocally endorsed the legalization of cannabis, the industry within the state has steadfastly pledged its commitment to ensuring a seamless transition and to nurturing economic prosperity throughout the region. However, the unprecedented level of enthusiasm and support that has been forthcoming over the past year has far exceeded all initial prognostications. This epoch shall be indelibly etched in the annals of history, not solely as a monumental stride in criminal justice reform within our state but also as the auspicious genesis of Missouri’s burgeoning billion-dollar sector, poised to fortify our economies and communities for generations to come.”
When juxtaposed with analogous jurisdictions, Missouri’s inaugural year of legalized sales conspicuously outshone that of some of its counterparts. For instance, New York, grappling with a sluggish commencement of its adult-use market, documented sales approximating a modest $150 million during its maiden year of legalization.
Moreover, the volume of sales achieved by Missouri in its debut year also surpassed, on a per capita basis, the legal sales recorded in Illinois during 2023. Illinois, renowned for its significantly more established cannabis market, reported approximately $1.6 billion in adult-use sales over the past year, despite boasting a population more than double that of Missouri.
Since the enactment of medical cannabis legalization, the state has accrued a noteworthy surplus of $150 million in revenue linked to cannabis, as emphasized in a recent in-depth examination conducted by the esteemed director of the state’s Division of Cannabis Regulation. This substantial fiscal accumulation not only underscores the economic vitality engendered by the burgeoning cannabis industry but also underscores the pivotal role it plays within the broader framework of state revenue generation and societal welfare initiatives.
Cannabis Revenue Boosts Veterans and Judicial Reform in Missouri

Amidst the ongoing fiscal period, slated for conclusion in July, Director Amy Moore has provided a comprehensive forecast, positing that the Missouri Veterans Commission stands to gain significantly from an estimated $19 million in revenue derived from cannabis-related activities. This figure, projected to ascend to a commendable $22 million in the subsequent fiscal year, underscores the palpable financial support earmarked for bolstering veterans’ services and programs within the state. To date, an impressive sum nearing the $40 million mark, sourced from medical cannabis sales revenue, has been earmarked for allocation to the commission, exemplifying a substantial commitment to honoring and assisting Missouri’s esteemed veterans.
Moreover, the financial contributions facilitated by these funds have extended beyond mere monetary allocations, playing an instrumental role in expunging over 100,000 previous cannabis-related charges from individuals’ criminal records. Despite this notable achievement, judicial administrators continue to advocate for an additional $3.7 million for the forthcoming budget year to ensure the expungement initiative reaches its full fruition, underscoring the persistent financial and administrative dedication to rectifying the lingering consequences of past cannabis laws.
As legislative activities persist within the state’s hallowed halls, a particularly noteworthy bill currently under consideration in the esteemed Senate seeks to introduce robust regulatory measures governing intoxicating hemp-derived cannabinoid products. Despite their current legal status stemming from their classification as hemp products, the absence of adequate regulation has prompted legislative efforts aimed at safeguarding consumer safety and addressing public health concerns comprehensively.
In a related legislative development, the August House of Representatives recently convened a deliberative session focusing on a forward-thinking proposal aimed at legalizing the medical application of psilocybin. This innovative initiative not only endeavors to sanction its therapeutic use but also mandates the implementation of rigorous clinical trials to explore the substance’s potential efficacy, thereby marking a significant stride towards broadening the spectrum of medical treatments available within the state.
Furthermore, the ongoing legislative discourse encompasses a diverse array of proposals, including a bill crafted to amend law enforcement practices by proscribing the utilization of cannabis odor as the exclusive criterion for warrantless searches of vehicles or properties. Concurrently, another legislative endeavor, championed by a bipartisan duo of esteemed Republican lawmakers, seeks to recalibrate workers’ compensation protocols. This particular bill aims to halve the compensation awards for workplace injuries in instances where the affected employee tests positive for cannabis use, irrespective of their degree of culpability in the incident, underscoring the intricate interplay between employment law and evolving cannabis policies.
In a laudable display of transparency and accountability, an annual review disseminated by the venerable Division of Cannabis Regulation has illuminated the demographic composition of applicants vying for the state’s coveted social equity cannabis licenses, which were initially issued in October. The insightful report has revealed that over 40 percent of the listed license owners hail from locales beyond the confines of Missouri, serving as a compelling testament to the diverse interest piqued by the state’s burgeoning cannabis industry. This revelation underscores the national appeal of Missouri’s progressive cannabis licensing initiatives, signaling a broader recognition of the state’s forward-looking regulatory framework and its potential to catalyze innovation and economic growth on a wider scale.